Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-RPS6 Antibody (R3P16) | Login | Anti-RPS6 Antibody (R3P16) | ||||||||||||||||
|
||||||||||||||||||
| Anti-HIST2H4A (20Me) Antibody (R3P17) | Login | Anti-HIST2H4A (20Me) Antibody (R3P17) | ||||||||||||||||
|
||||||||||||||||||
| Anti-HIST2H4A (20Me) Antibody (R3P18) | Login | Anti-HIST2H4A (20Me) Antibody (R3P18) | ||||||||||||||||
|
||||||||||||||||||
| Anti-HIST2H4A (20Me3) Antibody (R3P19) | Login | Anti-HIST2H4A (20Me3) Antibody (R3P19) | ||||||||||||||||
|
||||||||||||||||||
| Anti-HIST2H4A (20Me3) Antibody (R3P20) | Login | Anti-HIST2H4A (20Me3) Antibody (R3P20) | ||||||||||||||||
|
||||||||||||||||||
| Anti-GRB2 Antibody (R3P25) | Login | Anti-GRB2 Antibody (R3P25) | ||||||||||||||||
|
||||||||||||||||||
| Anti-GNAS Antibody (R3P27) | Login | Anti-GNAS Antibody (R3P27) | ||||||||||||||||
|
||||||||||||||||||
| Anti-GNAS Antibody (R3P28) | Login | Anti-GNAS Antibody (R3P28) | ||||||||||||||||
|
||||||||||||||||||
| Anti-SKP1 Antibody (R3P29) | Login | Anti-SKP1 Antibody (R3P29) | ||||||||||||||||
|
||||||||||||||||||
| Anti-SKP1 Antibody (R3P30) | Login | Anti-SKP1 Antibody (R3P30) | ||||||||||||||||
|
||||||||||||||||||
| Anti-BRAP Antibody (R4D06) | Login | Anti-BRAP Antibody (R4D06) | ||||||||||||||||
|
||||||||||||||||||
| Anti-CDC42BPB Antibody (R4D15) | Login | Anti-CDC42BPB Antibody (R4D15) | ||||||||||||||||
|
||||||||||||||||||
| Anti-MLH3 Antibody (R4D16) | Login | Anti-MLH3 Antibody (R4D16) | ||||||||||||||||
|
||||||||||||||||||
| Anti-VASH1 Antibody (R4D17) | Login | Anti-VASH1 Antibody (R4D17) | ||||||||||||||||
|
||||||||||||||||||
| Anti-VASH1 Antibody (R4D18) | Login | Anti-VASH1 Antibody (R4D18) | ||||||||||||||||
|
||||||||||||||||||
| Anti-BABAM1 Antibody (R4D22) | Login | Anti-BABAM1 Antibody (R4D22) | ||||||||||||||||
|
||||||||||||||||||
| Anti-NGDN Antibody (R4D24) | Login | Anti-NGDN Antibody (R4D24) | ||||||||||||||||
|
||||||||||||||||||
| Anti-NDUFAF2 Antibody (R4D32) | Login | Anti-NDUFAF2 Antibody (R4D32) | ||||||||||||||||
|
||||||||||||||||||
| Anti-STAG3 Antibody (R4D51) | Login | Anti-STAG3 Antibody (R4D51) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human FANCI Antibody (SAb2314) | Login | Anti-Human FANCI Antibody (SAb2314) | ||||||||||||||||
|
||||||||||||||||||
| InVivoMAb Anti-Human/Mouse TGF-β Antibody (1D11.16.8) | Login | InVivoMAb Anti-Human/Mouse TGF-β Antibody (1D11.16.8) | ||||||||||||||||
|
||||||||||||||||||
| InVivoMAb Anti-Mouse TNFα Antibody (XT3.11) | Login | InVivoMAb Anti-Mouse TNFα Antibody (XT3.11) | ||||||||||||||||
|
||||||||||||||||||
| InVivoMAb Anti-Human CD3 Antibody (OKT-3) | Login | InVivoMAb Anti-Human CD3 Antibody (OKT-3) | ||||||||||||||||
|
||||||||||||||||||
| InVivoMAb Anti-Human CD3 Antibody (UCHT1) | Login | InVivoMAb Anti-Human CD3 Antibody (UCHT1) | ||||||||||||||||
|
||||||||||||||||||
| InVivoMAb Anti-Mouse CD4 Antibody (GK1.5) | Login | InVivoMAb Anti-Mouse CD4 Antibody (GK1.5) | ||||||||||||||||
|
||||||||||||||||||


